The Role of Endoscopic Retrograde Cholangiopancreatography in Patients with Pancreatic Disease

Gastroenterology Clinics of North America

Volumn 41, Issue 1, 2012, Pages 23-45

  Buxbaum, James ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Congenital abnormalities; Endoscopic retrograde cholangiopancreatography; Fistula; Gallstones

Indexed keywords

BILIRUBIN; DICLOFENAC; GABEXATE MESILATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; SECRETIN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ALCOHOL CONSUMPTION; ANOMALOUS PANCREATICOBILIARY UNION; BALLOON DILATATION; BILE DUCT OBSTRUCTION; BILE DUCT PRESSURE; BILE DUCT STONE; BILIARY PANCREATITIS; BILIARY SLUDGE; BILIRUBIN BLOOD LEVEL; CANNULATION; CHOLANGITIS; CHOLECYSTECTOMY; CHRONIC CALCIFIC PANCREATITIS; CHRONIC PANCREATITIS; CONGENITAL DISORDER; CONSERVATIVE TREATMENT; DECOMPRESSION SURGERY; DISEASE SEVERITY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC PAPILLOTOMY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENDOSCOPIC THERAPY; EXTRACORPOREAL LITHOTRIPSY; FAMILY HISTORY; GALLSTONE; GALLSTONE PANCREATITIS; GOLD STANDARD; GUIDE WIRE; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PANCREATITIS; MANOMETRY; MICROLITHIASIS; PANCREAS DISEASE; PANCREAS DIVISUM; PANCREAS DUCT; PANCREATIC DUCT DISRUPTION; PANCREATIC DUCT LEAK; PANCREATIC DUCT STRICTURE; PANCREATIC STENT; PANCREATICOJEJUNOSTOMY; PANCREATITIS; PAPILLA CANNULATION; POST ERCP PANCREATITIS; RECURRENT PANCREATITIS; REVIEW; SPHINCTER OF ODDI DYSFUNCTION TYPE 1; SPHINCTER OF ODDI DYSFUNCTION TYPE 2; SPHINCTER OF ODDI DYSFUNCTION TYPE 3; SPHINCTEROTOMY; STENT; SURGICAL DRAINAGE; VATER PAPILLA STENOSIS;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; GALLSTONES; HUMANS; PANCREATIC DISEASES; PANCREATITIS; PANCREATITIS, CHRONIC;

EID: 84857082190     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.12.010     Document Type: Review

References (98)

1. Rhodes M., Sussman L., Cohen L., et al. Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde cholangiography for common bile duct stones. Lancet 1998, 351(9097):159-161.
2. Acosta J.M., Ledesma C.L. Gallstone migration as a cause of acute pancreatitis. N Engl J Med 1974, 290(9):484-487.
3. Fan S.T., Lai E.C., Mok F.P., et al. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 1993, 328(4):228-232.
4. Neoptolemos J.P., Carr-Locke D.L., London N.J., et al. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988, 2(8618):979-983.
5. Folsch U.R., Nitsche R., Ludtke R., et al. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med 1997, 336(4):237-242.
6. Kelly T.R., Wagner D.S. Gallstone pancreatitis: a prospective randomized trial of the timing of surgery. Surgery 1988, 104(4):600-605.
7. Tang E., Stain S.C., Tang G., et al. Timing of laparoscopic surgery in gallstone pancreatitis. Arch Surg 1995, 130(5):496-499. discussion 499-500.
8. Lee S.P., Nicholls J.F., Park H.Z. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992, 326(9):589-593.
9. Yusoff I.F., Raymond G., Sahai A.V. A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis. Gastrointest Endosc 2004, 60(5):673-678.
10. Okazaki K., Chiba T. Autoimmune related pancreatitis. Gut 2002, 51(1):1-4.
11. Kozarek R. Role of ERCP in acute pancreatitis. Gastrointest Endosc 2002, 56(6 Suppl):S231-S236.
12. Wilcox C.M., Varadarajulu S., Eloubeidi M. Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review. Gastrointest Endosc 2006, 63(7):1037-1045.
13. Frossard J.L., Sosa-Valencia L., Amouyal G., et al. Usefulness of endoscopic ultrasonography in patients with "idiopathic" acute pancreatitis. Am J Med 2000, 109(3):196-200.
14. Liu C.L., Lo C.M., Chan J.K., et al. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis. Gastrointest Endosc 2000, 51(1):28-32.
15. Tandon M., Topazian M. Endoscopic ultrasound in idiopathic acute pancreatitis. Am J Gastroenterol 2001, 96(3):705-709.
16. Coyle W.J., Pineau B.C., Tarnasky P.R., et al. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. Endoscopy 2002, 34(8):617-623.
17. Chak A., Hawes R.H., Cooper G.S., et al. Prospective assessment of the utility of EUS in the evaluation of gallstone pancreatitis. Gastrointest Endosc 1999, 49(5):599-604.
18. Catalano M.F., Lahoti S., Geenen J.E., et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998, 48(1):11-17.
19. Lai R., Freeman M.L., Cass O.W., et al. Accurate diagnosis of pancreas divisum by linear-array endoscopic ultrasonography. Endoscopy 2004, 36(8):705-709.
20. Levy M.J. The hunt for microlithiasis in idiopathic acute recurrent pancreatitis: should we abandon the search or intensify our efforts?. Gastrointest Endosc 2002, 55(2):286-293.
21. Kaw M., Brodmerkel G.J. ERCP, biliary crystal analysis, and sphincter of Oddi manometry in idiopathic recurrent pancreatitis. Gastrointest Endosc 2002, 55(2):157-162.
22. Dahan P., Andant C., Levy P., et al. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut 1996, 38(2):277-281.
23. Testoni P.A., Caporuscio S., Bagnolo F., et al. Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. Am J Gastroentero 2000, 95(7):1702-1707.
24. Kim H.S., Moon J.H., Choi H.J., et al. The role of intraductal US in the management of idiopathic recurrent pancreatitis without a definite cause on ERCP. Gastrointest Endosc 2011, 73(6):1148-1154.
25. Rashdan A., Fogel E., McHenry L., et al. Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction. Gastrointest Endosc 2003, 58(6):875-878.
26. Venu R.P., Geenen J.E., Hogan W., et al. Idiopathic recurrent pancreatitis. An approach to diagnosis and treatment. Dig Dis Sci 1989, 34(1):56-60.
27. Frulloni L., Cavallini G. Acute recurrent pancreatitis and dysfunction of the sphincter of Oddi: comparison between invasive and non-invasive techniques. JOP 2001, 2(6):406-413.
28. Toouli J., Roberts-Thomson I.C., Kellow J., et al. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 2000, 46(1):98-102.
29. Sherman S., Troiano F.P., Hawes R.H., et al. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol 1991, 86(5):586-590.
30. Eversman D., Fogel E.L., Rusche M., et al. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc 1999, 50(5):637-641.
31. Testoni P.A., Mariani A., Curioni S., et al. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes. Gastrointest Endosc 2008, 67(7):1028-1034.
32. Geenen J.E., Hogan W.J., Dodds W.J., et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med 1989, 320(2):82-87.
33. Park S.H., Watkins J.L., Fogel E.L., et al. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc 2003, 57(4):483-491.
34. Wehrmann T. Long-term results (>/= 10 years) of endoscopic therapy for sphincter of Oddi dysfunction in patients with acute recurrent pancreatitis. Endoscopy 2011, 43(3):202-207.
35. Saltzman J.R. Endoscopic treatment of pancreas divisum: why, when, and how?. Gastrointest Endosc 2006, 64(5):712-715.
36. Devereaux B.M., Lehman G.A., Fein S., et al. Facilitation of pancreatic duct cannulation using a new synthetic porcine secretin. Am J Gastroenterol 2002, 97(9):2279-2281.
37. Devereaux B.M., Fein S., Purich E., et al. A new synthetic porcine secretin for facilitation of cannulation of the dorsal pancreatic duct at ERCP in patients with pancreas divisum: a multicenter, randomized, double-blind comparative study. Gastrointest Endosc 2003, 57(6):643-647.
38. Park S.H., de Bellis M., McHenry L., et al. Use of methylene blue to identify the minor papilla or its orifice in patients with pancreas divisum. Gastrointest Endosc 2003, 57(3):358-363.
39. Attwell A., Borak G., Hawes R., et al. Endoscopic pancreatic sphincterotomy for pancreas divisum by using a needle-knife or standard pull-type technique: safety and reintervention rates. Gastrointest Endosc 2006, 64(5):705-711.
40. Heyries L., Barthet M., Delvasto C., et al. Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis. Gastrointest Endosc 2002, 55(3):376-381.
41. Ertan A. Long-term results after endoscopic pancreatic stent placement without pancreatic papillotomy in acute recurrent pancreatitis due to pancreas divisum. Gastrointest Endosc 2000, 52(1):9-14.
42. Lans J.I., Geenen J.E., Johanson J.F., et al. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc 1992, 38(4):430-434.
43. Lehman G.A., Sherman S., Nisi R., et al. Pancreas divisum: results of minor papilla sphincterotomy. Gastrointest Endosc 1993, 39(1):1-8.
44. Chacko L.N., Chen Y.K., Shah R.J. Clinical outcomes and nonendoscopic interventions after minor papilla endotherapy in patients with symptomatic pancreas divisum. Gastrointest Endosc 2008, 68(4):667-673.
45. Kozarek R.A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990, 36(2):93-95.
46. Sherman S., Hawes R.H., Savides T.J., et al. Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 1996, 44(3):276-282.
47. Guelrud M., Morera C., Rodriguez M., et al. Sphincter of Oddi dysfunction in children with recurrent pancreatitis and anomalous pancreaticobiliary union: an etiologic concept. Gastrointest Endosc 1999, 50(2):194-199.
48. Gress F., Yiengpruksawan A., Sherman S., et al. Diagnosis of annular pancreas by endoscopic ultrasound. Gastrointest Endosc 1996, 44(4):485-489.
49. Bhasin D.K., Rana S.S., Nanda M., et al. Ansa pancreatica type of ductal anatomy in a patient with idiopathic acute pancreatitis. JOP 2006, 7(3):315-320.
50. Hwang S.S., Paik C.N., Lee K.M., et al. Recurrent acute pancreatitis caused by an annular pancreas in a child. Gastrointest Endosc 2010, 72(4):848-849.
51. Dodda G., Brown R.D., O'Neil H.K., et al. Cystic duct insertion at ampulla as a cause for acute recurrent pancreatitis. Gastrointest Endosc 1998, 47(2):181-183.
52. Zoepf T., Zoepf D.S., Arnold J.C., et al. The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients. Gastrointest Endosc 2001, 54(1):56-61.
53. Dite P., Ruzicka M., Zboril V., et al. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis. Endoscopy 2003, 35(7):553-558.
54. Dumonceau J.M., Costamagna G., Tringali A., et al. Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomised controlled trial. Gut 2007, 56(4):545-552.
55. Mossner J., Secknus R., Meyer J., et al. Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial. Digestion 1992, 53(1-2):54-66.
56. Delhaye M., Arvanitakis M., Verset G., et al. Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis. Clin Gastroenterol Hepatol 2004, 2(12):1096-1106.
57. Smits M.E., Badiga S.M., Rauws E.A., et al. Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc 1995, 42(5):461-467.
58. Eleftherladis N., Dinu F., Delhaye M., et al. Long-term outcome after pancreatic stenting in severe chronic pancreatitis. Endoscopy 2005, 37(3):223-230.
59. Rosch T., Daniel S., Scholz M., et al. Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy 2002, 34(10):765-771.
60. Cahen D.L., Gouma D.J., Nio Y., et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007, 356(7):676-684.
61. Cahen D.L., Gouma D.J., Laramee P., et al. Long-term outcomes of endoscopic versus surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology 2011, 141(5):1690-1695.
62. Kozarek R.A., Brandabur J.J., Ball T.J., et al. Clinical outcomes in patients who undergo extracorporeal shock wave lithotripsy for chronic calcific pancreatitis. Gastrointest Endosc 2002, 56(4):496-500.
63. Brand B., Kahl M., Sidhu S., et al. Prospective evaluation of morphology, function, and quality of life after extracorporeal shockwave lithotripsy and endoscopic treatment of chronic calcific pancreatitis. Am J Gastroenterol 2000, 95(12):3428-3438.
64. Costamagna G., Bulajic M., Tringali A., et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy 2006, 38(3):254-259.
65. Moon S.H., Kim M.H., Park do H., et al. Modified fully covered self-expandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced chronic pancreatitis, with a focus on the safety profile and reducing migration. Gastrointest Endosc 2010, 72(1):86-91.
66. Sauer B., Talreja J., Ellen K., et al. Temporary placement of a fully covered self-expandable metal stent in the pancreatic duct for management of symptomatic refractory chronic pancreatitis: preliminary data (with videos). Gastrointest Endosc 2008, 68(6):1173-1178.
67. Ostroff J.W. Pain and chronic pancreatitis: are we really ready for metal in the pancreatic duct?. Gastrointest Endosc 2008, 68(6):1179-1181.
68. Deviere J., Bueso H., Baize M., et al. Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc 1995, 42(5):445-451.
69. Varadarajulu S., Noone T.C., Tutuian R., et al. Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement. Gastrointest Endosc 2005, 61(4):568-575.
70. Costamagna G., Mutignani M., Ingrosso M., et al. Endoscopic treatment of postsurgical external pancreatic fistulas. Endoscopy 2001, 33(4):317-322.
71. Bracher G.A., Manocha A.P., DeBanto J.R., et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc 1999, 49(6):710-715.
72. Trevino J.M., Tamhane A., Varadarajulu S. Successful stenting in ductal disruption favorably impacts treatment outcomes in patients undergoing transmural drainage of peripancreatic fluid collections. J Gastroenterol Hepatol 2010, 25(3):526-531.
73. Lau S.T., Simchuk E.J., Kozarek R.A., et al. A pancreatic ductal leak should be sought to direct treatment in patients with acute pancreatitis. Am J Surg 2001, 181(5):411-415.
74. Telford J.J., Farrell J.J., Saltzman J.R., et al. Pancreatic stent placement for duct disruption. Gastrointest Endosc 2002, 56(1):18-24.
75. Lawrence C., Howell D.A., Stefan A.M., et al. Disconnected pancreatic tail syndrome: potential for endoscopic therapy and results of long-term follow-up. Gastrointest Endosc 2008, 67(4):673-679.
76. Baron T.H., Ferreira L.E. Covered expandable metal stent placement for treatment of a refractory pancreatic duct leak. Gastrointest Endosc 2007, 66(6):1239-1241.
77. Luthen R., Jaklin P., Cohnen M. Permanent closure of a pancreatic duct leak by endoscopic coiling. Endoscopy 2007, 39(Suppl 1):E21-E22.
78. Sherman S., Blaut U., Watkins J.L., et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003, 58(1):23-29.
79. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37(3):383-393.
80. Freeman M.L., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001, 54(4):425-434.
81. Disario J.A., Freeman M.L., Bjorkman D.J., et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 2004, 127(5):1291-1299.
82. Singh P., Gurudu S.R., Davidoff S., et al. Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 2004, 59(4):499-505.
83. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006, 101(1):139-147.
84. Badalov N., Tenner S., Baillie J. The Prevention, recognition and treatment of post-ERCP pancreatitis. JOP 2009, 10(2):88-97.
85. Shao L.M., Chen Q.Y., Chen M.Y., et al. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci 2010, 55(1):1-7.
86. Andriulli A., Leandro G., Federici T., et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007, 65(4):624-632.
87. Murray B., Carter R., Imrie C., et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003, 124(7):1786-1791.
88. Elmunzer B.J., Waljee A.K., Elta G.H., et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008, 57(9):1262-1267.
89. Dumonceau J.M., Andriulli A., Deviere J., et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010, 42(6):503-515.
90. Cheon Y.K., Cho K.B., Watkins J.L., et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc 2007, 66(6):1126-1132.
91. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. A meta-analysis of controlled trials. Gastrointest Endosc 2004, 60(4):544-550.
92. Das A., Singh P., Sivak M.V., et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007, 65(7):960-968.
93. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998, 115(6):1518-1524.
94. Freeman M.L., Overby C., Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004, 59(1):8-14.
95. Neuhaus H. Therapeutic pancreatic endoscopy. Endoscopy 2004, 36(1):8-16.
96. Cennamo V., Fuccio L., Zagari R.M., et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2009, 104(9):2343-2350.
97. Reddy N., Wilcox C.M., Tamhane A., et al. Protocol-based medical management of post-ERCP pancreatitis. J Gastroenterol Hepatol 2008, 23(3):385-392.
98. Warndorf M.G., Kurtzman J.T., Bartel M.J., et al. Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroenterol Hepatol 2011, 9(8):705-709.